Accuracy of FDG-PET-CT in the diagnostic work-up of vascular prosthetic graft infection

Eur J Vasc Endovasc Surg. 2010 Sep;40(3):348-54. doi: 10.1016/j.ejvs.2010.05.016. Epub 2010 Jun 23.

Abstract

Objectives: To investigate the diagnostic accuracy of fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) compared with computed tomography (CT) scanning and added value of fused FDG-PET-CT in diagnosing vascular prosthetic graft infection.

Design: Prospective cohort study with retrospective analysis.

Materials: Twenty five patients with clinically suspected vascular prosthetic infection underwent CT and FDG-PET scanning.

Methods: Two nuclear medicine physicians assessed the FDG-PET scans; all CT scans were assessed by two radiologists. Fused FDG-PET/CT were judged by the radiologist and the nuclear medicine physician. The concordance between CT and FDG-PET and the inter-observer agreement between the different readers were investigated.

Results: Fifteen patients had a proven infection by culture. Single FDG-PET had the best results (sensitivity 93%, specificity 70%, positive predictive value 82% and negative predictive value 88%). For CT, these values were 56%, 57%, 60% and 58%, respectively. Fused CT and FDG-PET imaging also showed high sensitivity and specificity rates and high positive and negative values. Inter-observer agreement for FDG-PET analysis was excellent (kappa = 1.00) and moderate for CT and fused FDG-PET-CT analysis (0.63 and 0.66, respectively).

Conclusion: FDG-PET scanning showed a better diagnostic accuracy than CT for the detection of vascular prosthetic infection. This study suggests that FDG-PET provides a useful tool in the work-up for diagnosis of vascular prosthetic graft infection.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Blood Vessel Prosthesis / adverse effects*
  • Blood Vessel Prosthesis Implantation / adverse effects*
  • Blood Vessel Prosthesis Implantation / instrumentation
  • Female
  • Fluorodeoxyglucose F18*
  • Humans
  • Male
  • Middle Aged
  • Observer Variation
  • Positron-Emission Tomography*
  • Predictive Value of Tests
  • Prosthesis-Related Infections / diagnosis*
  • Prosthesis-Related Infections / diagnostic imaging
  • Prosthesis-Related Infections / etiology*
  • Prosthesis-Related Infections / microbiology
  • Radiopharmaceuticals*
  • Reproducibility of Results
  • Retrospective Studies
  • Sensitivity and Specificity
  • Tomography, X-Ray Computed*

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18